Skip to content
April 25, 2024

Equity.Guru

Investment information for the new generation

Search

Biotech innovation

Counting Sheep   For me, sleeping is both a blessing and a curse. While I love nothing more than laying in bed after a long day, I hate waking…
Eye Don’t Believe It   Fill Disclosure: weekly roundups are intended to provide a quick introduction to various companies. They are not intended to be deep dives or opinion…
Miraculous Microchip   Yes, you read that right. Earlier this week, German Aldana Zuniga got behind the wheel of an 850 horsepower NASCAR Cup race car. At first glance, this…
A Pain in the Behind   I don’t fear a lot of things. Well, other than spiders, heights, and being stabbed. However, more than anything I have always been afraid…
Smart Watch, Healthy Heart   There was an opportunity for a pun in the headline and I took it. In this week’s sector roundup, we are going to be…
Nice Mice   Considering the amount of junk food I have eaten in the past week, I figured now is as good a time as any to talk about…
Old Memories I have always been a sucker for nostalgia. When I first started writing for Equity Guru, I spent most of my time covering biotechnology companies. Whether they…
Spruce Biosciences Inc. (SPRB.Q) is a late-stage biopharmaceutical company developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical needs. The Company is credited for developing its…
The history of humanity is the history of disease. We’ve mostly bumbled around from plague to plague, blind-sided and punch drunk by the ferocity of our unseen foe. Mostly,…
Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to…